NPPA caps trade margins on 137 cancer drugs at 30%, new prices from November 9
The drug pricing regulator has notified a 30% cap on trade margins for 137 non-scheduled anti-cancer drugs. The government says retail prices could fall by up to 70%, depending on the drug.